10 Unknown Biotech Stocks That Can Explode in 2022
In this article, we discuss the 10 unknown biotech stocks that can explode in 2022.
Vyne Therapeutics Inc. (VYNE)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Cormorant Asset Management Bihua Chen | 1,394,336 | $4,671,026 | 0.25% | |
| 2. | Citadel Investment Group Ken Griffin | 1,230,457 | $4,122,031 | +4% | 0% |
| 3. | Palo Alto Investors William Leland Edwards | 445,434 | $1,492,204 | 0.23% | |
| 4. | Exome Asset Management Samuel Isaly | 353,434 | $1,184,004 | 0.88% | |
| 5. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 176,658 | $591,804 | +5% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.92 | 15,000 | 51,472 | 2025-01-15 | Filing | ||
| $3.91 | 13,000 | Director | 36,472 | 2023-11-15 | Filing | |
| $2.48 | 20,000 | Director | 23,472 | 2023-03-20 | Filing | |
| $2.50 | 10,000 | Officer | 22,721 | 2023-03-20 | Filing | |
| $1.02 | 12,500 | Director | 62,500 | 2021-11-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.74 | 250,000 | Large Shareholder | 4,935,057 | 2021-08-16 | Filing | |
| $1.84 | 250,000 | Large Shareholder | 5,185,057 | 2021-08-13 | Filing | |
| $2.23 | 338,897 | Large Shareholder | 5,435,057 | 2021-08-12 | Filing | |
| $3.67 | 1,000,000 | Large Shareholder | 5,773,954 | 2021-05-06 | Filing | |
| $7.65 | 12,500 | Other | 48,910 | 2018-07-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,394,336 | $4,447,932 | 0.08% | |
| 2. | 475,129 | $1,591,682 | 0% | |
| 3. | 456,970 | $1,530,850 | 0.82% | |
| 4. | 245,800 | $823,430 | 0.06% | |
| 5. | 135,017 | $452,338 | 0% |
News See All
Should I Buy VYNE Therapeutics Inc. (VYNE)?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
5 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman
In this article, we discuss the 5 best pharmaceutical stocks to buy according to billionaire Joseph Edelman.
Hedge Fund and Insider Trading News: Crispin Odey, Stanley Druckenmiller, Bill Miller, Renaissance Technologies, Elliott Management, ApaH Capital, Harley-Davidson Inc (HOG), Meridian Bioscience Inc (VIVO), and More
For years, Renaissance Technologies was among the most exalted names in high finance, as close to a sure-thing as Wall Street had.
Is VYNE A Good Stock To Buy Now?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Billionaire Hedge Funds
